skip to main content

Content language

Contact us: CRM@email.irandoc.ac.ir

Concept information

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > liposaccharide > glycolipid > glycosphingolipid > neolacto-series glycosphingolipid > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-d-galactosaminyl-(1->3)-(alpha-l-fucosyl-(1->2))-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-) > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-d-galactosaminyl-(1->3)-(alpha-l-fucosyl-(1->2))-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d18:1(4e))(1-)
... > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > liposaccharide > glycolipid > glycosphingolipid > neolacto-series glycosphingolipid > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-d-galactosaminyl-(1->3)-(alpha-l-fucosyl-(1->2))-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-) > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-d-galactosaminyl-(1->3)-(alpha-l-fucosyl-(1->2))-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d18:1(4e))(1-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > glycosphingolipid > neolacto-series glycosphingolipid > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-d-galactosaminyl-(1->3)-(alpha-l-fucosyl-(1->2))-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-) > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-d-galactosaminyl-(1->3)-(alpha-l-fucosyl-(1->2))-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d18:1(4e))(1-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > glycosphingolipid > neolacto-series glycosphingolipid > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-d-galactosaminyl-(1->3)-(alpha-l-fucosyl-(1->2))-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-) > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-d-galactosaminyl-(1->3)-(alpha-l-fucosyl-(1->2))-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d18:1(4e))(1-)
... > organooxygen compound > sphingolipid > glycosphingolipid > neolacto-series glycosphingolipid > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-d-galactosaminyl-(1->3)-(alpha-l-fucosyl-(1->2))-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-) > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-d-galactosaminyl-(1->3)-(alpha-l-fucosyl-(1->2))-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d18:1(4e))(1-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > ceramide > ganglioside > sialodecaosylceramide > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-d-galactosaminyl-(1->3)-(alpha-l-fucosyl-(1->2))-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-) > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-d-galactosaminyl-(1->3)-(alpha-l-fucosyl-(1->2))-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d18:1(4e))(1-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > ceramide > ganglioside > sialodecaosylceramide > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-d-galactosaminyl-(1->3)-(alpha-l-fucosyl-(1->2))-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-) > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-d-galactosaminyl-(1->3)-(alpha-l-fucosyl-(1->2))-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d18:1(4e))(1-)
... > organooxygen compound > sphingolipid > ceramide > ganglioside > sialodecaosylceramide > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-d-galactosaminyl-(1->3)-(alpha-l-fucosyl-(1->2))-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-) > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-d-galactosaminyl-(1->3)-(alpha-l-fucosyl-(1->2))-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d18:1(4e))(1-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > carboxamide > ceramide > ganglioside > sialodecaosylceramide > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-d-galactosaminyl-(1->3)-(alpha-l-fucosyl-(1->2))-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-) > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-d-galactosaminyl-(1->3)-(alpha-l-fucosyl-(1->2))-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d18:1(4e))(1-)
... > organooxygen compound > carboxamide > ceramide > ganglioside > sialodecaosylceramide > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-d-galactosaminyl-(1->3)-(alpha-l-fucosyl-(1->2))-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-) > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-d-galactosaminyl-(1->3)-(alpha-l-fucosyl-(1->2))-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d18:1(4e))(1-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > amide > primary amide > carboxamide > ceramide > ganglioside > sialodecaosylceramide > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-d-galactosaminyl-(1->3)-(alpha-l-fucosyl-(1->2))-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-) > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-d-galactosaminyl-(1->3)-(alpha-l-fucosyl-(1->2))-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d18:1(4e))(1-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > liposaccharide > glycolipid > glycosphingolipid > acidic glycosphingolipid > ganglioside > sialodecaosylceramide > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-d-galactosaminyl-(1->3)-(alpha-l-fucosyl-(1->2))-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-) > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-d-galactosaminyl-(1->3)-(alpha-l-fucosyl-(1->2))-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d18:1(4e))(1-)
... > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > liposaccharide > glycolipid > glycosphingolipid > acidic glycosphingolipid > ganglioside > sialodecaosylceramide > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-d-galactosaminyl-(1->3)-(alpha-l-fucosyl-(1->2))-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-) > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-d-galactosaminyl-(1->3)-(alpha-l-fucosyl-(1->2))-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d18:1(4e))(1-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > glycosphingolipid > acidic glycosphingolipid > ganglioside > sialodecaosylceramide > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-d-galactosaminyl-(1->3)-(alpha-l-fucosyl-(1->2))-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-) > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-d-galactosaminyl-(1->3)-(alpha-l-fucosyl-(1->2))-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d18:1(4e))(1-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > glycosphingolipid > acidic glycosphingolipid > ganglioside > sialodecaosylceramide > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-d-galactosaminyl-(1->3)-(alpha-l-fucosyl-(1->2))-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-) > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-d-galactosaminyl-(1->3)-(alpha-l-fucosyl-(1->2))-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d18:1(4e))(1-)
... > organooxygen compound > sphingolipid > glycosphingolipid > acidic glycosphingolipid > ganglioside > sialodecaosylceramide > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-d-galactosaminyl-(1->3)-(alpha-l-fucosyl-(1->2))-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(1-) > n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-d-galactosaminyl-(1->3)-(alpha-l-fucosyl-(1->2))-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d18:1(4e))(1-)

Preferred term

n-acetyl-alpha-neuraminosyl-(2->3)-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-d-galactosaminyl-(1->3)-(alpha-l-fucosyl-(1->2))-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d18:1(4e))(1-)  

Type

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

charge

  • -1

formula

  • C98H164N6O60R

mass

  • 2386.359

monoisotopicmass

  • 2384.99663

smiles

  • [C@@H]1([C@@H]([C@H]([C@H]([C@H](O1)CO[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O[C@@H]4[C@@H]([C@H]([C@H]([C@H](O4)CO)O)O)NC(C)=O)O[C@H]5[C@H]([C@@H]([C@@H]([C@@H](O5)C)O)O)O)O)NC(C)=O)O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O[C@H]7[C@@H]([C@H]([C@H]([C@H](O7)CO)O)O[C@]8(O[C@]([C@@H]([C@H](C8)O)NC(C)=O)([C@@H]([C@@H](CO)O)O)[H])C([O-])=O)O)O)NC(C)=O)O)O[C@H]9[C@@H]([C@H]([C@@H](O[C@@H]9CO)O[C@@H]%10[C@H]([C@@H](O[C@@H]([C@@H]%10O)CO)O[C@H]%11[C@@H]([C@H]([C@@H](O[C@@H]%11CO)OC[C@@H]([C@@H](/C=C/CCCCCCCCCCCCC)O)NC(=O)*)O)O)O)NC(C)=O)O

subset

  • 2_STAR

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:145366

Download this concept: